Skip to content

Author

Tz-Chuen Ju

We have 1 of 21 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

IL17A disrupts autophagy-lysosomal function and lysosome reformation through the GSK3B-TFE3 signaling pathway in Huntington disease.

Therapeutic neutralization of IL17A with a monoclonal antibody (IL17A mAb) ameliorates disease phenotypes in R6/2 HD mice, improving motor performance, extending survival, and reducing gliosis, and highlights IL17A inhibition as a promising therapeutic strategy for targeting autophagy-lysosomal dysfunction in HD.

Kai-Po Chen, Tz-Chuen Ju · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.